跳至主要内容
临床试验/NCT02116075
NCT02116075Unknown2 期

Caudal Corticosteroid vs. Dextrose Injection for Lumbosacral Radicular Pain.

Naveed Natanzi1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2015年1月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
发起方
入组人数
50
试验地点
1
主要终点
Pain relief as measured by VAS pain scale.

研究概览

简要总结

Study comparing caudal prolotherapy to conventional steroid for chronic low back pain

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participants must satisfy diagnostic criteria for lumbar radicular pain at L4 nerve root level or below with consistent MRI or X ray findings.
  • •Evidence of low back pain base upon one or more of the following:
  • •i. Lumbar back pain episodes lasting greater than 6 months and current pain level is greater than 6/10 on VAS.
  • •ii. Has received at lest 2 types of ancillary treatment (i.e. physical therapy, oral analgesia, acupuncture, etc.)
  • •Men or women age greater than or equal to 18 years.
  • •No significant alcohol use (7 or fewer drinks per week).
  • •Patient has a history of at least 2 failed epidural CS injections.

排除标准

  • •Treatment risk factors including one or more of the following:
  • •i. Unstable or symptomatic cardiac complaints ii. Unstable or symptomatic respiratory complaints iii. Unable to reliably comprehend the protocol or reliably record data
  • •Pregnancy. A serum pregnancy test must be performed and negative in all women of child bearing potential within 2 weeks prior to enrollment.
  • •History of Malignancy
  • •Any medical (i.e. malignancy, infection, thrombo-embolic states, autoimmune disease, polyneuropathy) or psychosocial condition that in the opinion of the investigator, could jeopardize the subject's participation, and compliance with the study criteria.

研究组 & 干预措施

Epidural Steroid

Experimental

80mg depo-medrol 9mL 1% lidocaine

干预措施: Epidural Prolotherapy (Procedure)

Epidural Prolotherapy

Active Comparator

10ml of 5% generic dextrose

干预措施: Epidural Steroid (Procedure)

结局指标

主要结局

Pain relief as measured by VAS pain scale.

时间窗: 1 year

次要结局

  • Disability score as determined by Oswstery questionnaire.(1 year)
  • Change in the frequency and amount of opioid use.(1 year)

研究者

发起方
Naveed Natanzi
申办方类型
Fed
责任方
Sponsor Investigator
主要研究者

Naveed Natanzi

Resident Physician

VA Long Beach Healthcare System

研究点 (1)

Loading locations...

相似试验